CSS Button No Image Css3Menu.com

Baseball Prospectus home
  
  
Click here to log in Click here for forgotten password Click here to subscribe

Premium and Super Premium Subscribers Get a 20% Discount at MLB.tv!

Articles Tagged PEDs 

Search BP Articles

All Blogs (including podcasts)

Active Columns

Authors

Article Types

Archives

07-08

comment icon

0

BP Daily Podcast: Effectively Wild Episode 487: Ballplayers Say the Darndest Things
by
Ben Lindbergh and Sam Miller

05-30

comment icon

1

BP Daily Podcast: Effectively Wild Episode 460: Nelson Cruz, Ryan Braun, and the Post-PED Good Life
by
Ben Lindbergh and Sam Miller

04-17

comment icon

1

BP Daily Podcast: Effectively Wild Episode 430: Dirk Hayhurst on Cheating, Beaning, and Clubhouse Race Relations
by
Ben Lindbergh and Russell A. Carleton

04-03

comment icon

2

BP Daily Podcast: Effectively Wild Episode 420: Yost, Replay, Porter, and PEDs
by
Ben Lindbergh and Sam Miller

04-02

comment icon

12

BP Unfiltered: Do the Rays Have a Drug Problem?
by
Ben Lindbergh

02-11

comment icon

54

Barry Bonds, Race, and Public Perception
by
Lewie Pollis

01-14

comment icon

30

Analyzing A-Rod's Arbitration Case
by
Eugene Freedman

01-13

comment icon

0

BP Daily Podcast: Effectively Wild Episode 363: Yankees Beat Writer Andy McCullough on Alex Rodriguez, Again
by
Ben Lindbergh and Sam Miller

12-02

comment icon

5

BP Daily Podcast: Effectively Wild Episode 339: Alex Rodriguez, Bud Selig, and Hard-Boiled Baseball
by
Ben Lindbergh and Sam Miller

11-25

comment icon

0

BP Daily Podcast: Effectively Wild Episode 336: Paying Peralta, and Punishing PED Users
by
Ben Lindbergh and Sam Miller

11-21

comment icon

13

Analyzing A-Rod's Arbitration Case
by
Eugene Freedman

10-08

comment icon

9

Analyzing A-Rod's Arbitration Case
by
Eugene Freedman

09-10

comment icon

0

BP Daily Podcast: Effectively Wild Episode 283: An Upper-Minors Inefficiency/The Slippery Definition of Performance Enhancement
by
Ben Lindbergh and Sam Miller

08-20

comment icon

28

Baseball ProGUESTus: Giving Up the PED Guessing Game
by
Gabe Kapler

08-20

comment icon

5

Transaction Analysis: Boston, Xander Bogaerts, and the Return of Ultra-Young Talent
by
Ben Lindbergh

08-05

comment icon

21

Manufactured Runs: Biogenesis and Baseball's Post-Human Present
by
Colin Wyers

07-31

comment icon

4

BP Daily Podcast: Effectively Wild Episode 255: Listener Emails Like Never Before
by
Ben Lindbergh and Sam Miller

07-23

comment icon

54

Overthinking It: Ryan Braun, Biogenesis, and Betrayal
by
Ben Lindbergh

07-22

comment icon

0

BP Daily Podcast: Effectively Wild Episode 248: Bartolo Colon and the PED Question/Ruben Amaro and Prospect Rankings
by
Ben Lindbergh and Sam Miller

06-06

comment icon

0

BP Daily Podcast: Effectively Wild Episode 218: Paralysis by Biogenesis
by
Ben Lindbergh and Sam Miller

06-05

comment icon

20

Bizball: Suspensions May Loom for Players Connected to Biogenesis Clinic
by
Maury Brown

02-26

comment icon

33

Baseball ProGUESTus: Surviving Professional Baseball in the Steroid Era
by
Eric Knott

01-16

comment icon

0

BP Daily Podcast: Effectively Wild Episode 120: Quantifying PED Effects/Best Farm Systems in Baseball/Roleplaying Trade Talks
by
Ben Lindbergh and Sam Miller

01-11

comment icon

5

The BP Wayback Machine: Bagging on Bagwell
by
Christina Kahrl

08-15

comment icon

24

BP Unfiltered: Melky Cabrera, PEDs, and the Giants' Playoff Odds
by
Ben Lindbergh

06-11

comment icon

9

Bizball: Inside the 2012-16 MLB CBA: Major Changes Come to the League’s Drug Policy
by
Maury Brown

12-28

comment icon

42

Prospectus Hit and Run: The Class of 2012: The First Basemen
by
Jay Jaffe

12-12

comment icon

9

Wezen-Ball: Braun, a Hometown View
by
Larry Granillo

12-23

comment icon

16

Prospectus Hit and Run: The Class of 2011: Bagwell and Baggage
by
Jay Jaffe

02-09

comment icon

139

Prospectus Today: Stupid Media Tricks
by
Joe Sheehan

02-06

comment icon

6

Legally Brief
by
Keith Scherer

01-25

comment icon

0

Prospectus Hit and Run: PEDs and Discontent
by
Jay Jaffe

01-16

comment icon

0

Stupid Lawyer Tricks
by
Derek Jacques

12-20

comment icon

0

Schrodinger's Bat: The Issue of the Day, and Ranging into the Outfield
by
Dan Fox

08-09

comment icon

0

Bonds Responses
by
Baseball Prospectus

05-22

comment icon

0

Prospectus Today: Break with the Past
by
Joe Sheehan

06-12

comment icon

0

Prospectus Today: Witch Hunt
by
Joe Sheehan

<< Previous Tag Entries Next Tag Entries >>

Ben and Sam talk about whether teams should step up advance scouting in the upper minors, then discuss the difference (or lack thereof) between the PEDs MLB bans and the procedures it allows.

Read the full article...

A plea to stop the speculation from a player who's heard more than his fair share.

Most of our writers didn't enter the world sporting an @baseballprospectus.com address; with a few exceptions, they started out somewhere else. In an effort to up your reading pleasure while tipping our caps to some of the most illuminating work being done elsewhere on the internet, we'll be yielding the stage once a week to the best and brightest baseball writers, researchers, and thinkers from outside of the BP umbrella. If you'd like to nominate a guest contributor (including yourself), please drop us a line.

Gabe Kapler spent parts of 12 years in the major leagues from 1998-2010, playing for the Tigers (1998-99), Rangers (2000-02), Rockies (2002-03), Red Sox (2003-06 – with a brief interlude in Japan), Brewers (2008) and Rays (2009-10). He also spent a year managing the Red Sox’ Single-A affiliate in Greenville. Follow him on Twitter @gabekapler. You can read his first article for BP here and listen to his recent discussion of advanced stats on Effectively Wild with Ben Lindbergh and Sam Miller here.

Read the full article...

What Xander Bogaerts' promotion means for the Red Sox and for the rise of young talent in the post-PED era.


Note: originally published on Monday, August 19.


The rest of this article is restricted to Baseball Prospectus Subscribers.

Not a subscriber?

Click here for more information on Baseball Prospectus subscriptions or use the buttons to the right to subscribe and get access to the best baseball content on the web.


Cancel anytime.


That's a 33% savings over the monthly price!


That's a 33% savings over the monthly price!

Already a subscriber? Click here and use the blue login bar to log in.

The real danger Biogenesis revealed and the false threat that we shouldn't make this about.

The announcement was mostly anticlimax. Twelve players accepted 50-game suspensions for their involvement with the Biogenesis clinic, and Alex Rodriguez is looking at a longer suspension pending appeal. Some of the names are a surprise, but not the name that everyone is talking about.

The Biogenesis story has, admittedly at the urging of MLB, become primarily about Alex Rodriguez and his massive contract, and Ryan Braun and his improperly handled sample. It is understandable, in that they’re both big stars and the storylines around them are indeed compelling. But there’s a larger story here that’s mostly being missed.

The remainder of this post cannot be viewed at this subscription level. Please click here to subscribe.

Ben and Sam answer listener emails about the consequences of abolishing the trade deadline, baseball's war on PEDs, time traveling front offices, and more.

Read the full article...

Why Ryan Braun's suspension isn't bad news, and other reflections on the latest in the Biogenesis saga.

Baseball Prospectus has no house style on performance-enhancing drugs, the way we do about, say, punctuation (unspaced em-dash only, please). We haven’t taken an internal poll and decided to condone or condemn PEDs, and we don’t issue an official stance on steroids as part of the author orientation process. But a site devoted to the pursuit of objective knowledge about baseball tends to attract a group of authors who’ve independently developed similar feelings about certain subjects—from batting order to the sacrifice bunt—and so much of our coverage of baseball’s PED problem over the years has held true to a few first principles:

Read the full article...

Ben and Sam talk about whether it's ever fair to suspect that a player is taking PEDs, then discuss Ruben Amaro's comments about public prospect rankings.

Read the full article...

Ben and Sam discuss the latest developments in the Biogenesis saga.

Read the full article...

Some 20 players could be suspended for ties to Biogenesis, as the league seeks testimony from Tony Bosch in a case that could have far-reaching financial implications.

Major League Baseball may seek to suspend as many as 20 players, including Alex Rodriguez and Ryan Braun, as part of the investigation into the Miami-area Biogenesis anti-aging clinic, according to a report by ESPN. The league has been pursuing legal avenues, including a lawsuit against Biogenesis, Biokem, Tony Bosch of Biogenesis, and others, seeking damages. That and other pressure may have finally taken a toll on Bosch as, according to the ESPN report, he is ready to cooperate with MLB investigators in exchange for their dropping the case. With Bosch testifying against players, the league could begin the suspension process “within the next few weeks.”

Should all the players be suspended, it would mark the largest number of suspensions for performance-enhancing substances in the history of professional sports. In 2005, the first year of mandatory drug testing, MLB suspended 12 players between April and November of the year, the largest amount of suspensions at the major-league level to date. At the time, first-time suspensions against the joint drug agreement between MLB and the players’ union were only for 10 games. Since then, the number of games a player can be suspended for has increased dramatically to 50 for a first violation, 100 for a second, and a potential permanent suspension from both MLB and minor-league baseball for a third.

The remainder of this post cannot be viewed at this subscription level. Please click here to subscribe.

Former fringe major leaguer Eric Knott dishes on his difficult decisions about PED use during his time as a professional player.

Most of our writers didn't enter the world sporting an @baseballprospectus.com address; with a few exceptions, they started out somewhere else. In an effort to up your reading pleasure while tipping our caps to some of the most illuminating work being done elsewhere on the internet, we'll be yielding the stage once a week to the best and brightest baseball writers, researchers and thinkers from outside of the BP umbrella. If you'd like to nominate a guest contributor (including yourself), please drop us a line.

Eric Knott is a former big-league pitcher who threw a combined 24 innings in the majors for the 2001 Diamondbacks and the 2003 Expos. While he was there, he struck out Chipper and Andruw Jones, Luis Gonzalez, Scott Rolen, Jim Thome, Chase Utley, and Miguel Cabrera (twice). He had an 11-year minor-league career from 1997-2007, pitching for four MLB organizations, as well as the Pericos de Puebla of the Mexican League. You can follow him on Twitter @eknott11.
 


Read the full article...

Ben and Sam answer listener emails about how much steroids help, the best farm systems in baseball, and how they'd try to negotiate a hypothetical trade.



Read the full article...

Character assassination, speculation, a commitment to process... ah, it has to be Hall of Fame season.

While looking toward the future with our comprehensive slate of current content, we'd also like to recognize our rich past by drawing upon our extensive (and mostly free) online archive of work dating back to 1997. In an effort to highlight the best of what's gone before, we'll be bringing you a weekly blast from BP's past, introducing or re-introducing you to some of the most informative and entertaining authors who have passed through our virtual halls. If you have fond recollections of a BP piece that you'd like to nominate for re-exposure to a wider audience, send us your suggestion.

Before Jeff Bagwell's first year on the Hall of Fame ballot, Christina summed up her attitude toward steroids in the piece reprinted below, which was originally published as a "Prospectus Perspective" column on December 31st, 2010.
 


Read the full article...

<< Previous Tag Entries Next Tag Entries >>